I'm not sure I agree. My understanding is that Apple already asked the Appeals court to step in and they declined to. The only other step I can see is Apple asking SCOTUS to step in, but I doubt very strongly they would grant cert. Would these "Mangrove IPRs" be a different issue that wasn't part of Apple's ask of the Appeals court back in February? There's a lot of issues and suits going on here: I read an interview with one of the attorneys for VHC that patent validity issues were somehow estopped, so why would the issues re: IPRs even matter for the purpose of this case?

Thank you

I’m expecting January revs announcement. Also, could Q42020 be the quarter EPS is > -0.01?

Impressive

Go read the financials

Oh this looks good

In @ $1.78

Would love to know

Hmmmm

10-Q coming soon. EPS, will be looking

I can't wait to see the quarterly report... GLTA.

$5.1 million revs in October. Market cap $6.2 million.

Wow, nice.

Bizarre price and volume action today—more shorts covering? I can't find any catalyst.

Looking forward to quarterly #s

Never said I was a good guesser!

I'm guessing a close near HOD.

When will fins be filed?

Nice bid size

Looking good

$0.0372/750,000

Bought 0.034. Good news that docket is being updated, expecting signature before close.

Thanks

Nice! Will put on watch.

At present market value, 2,500 shares is $1,075.

Adding $0.1091

on 2,300 shares.

Done!

Sold $EYES in $IQST

I'm predicting $.05 EOD. IMO. GLTA.

100%

Sold $EYES bought $BRTXQ

Stock behavior is interesting in since this filing... thoughts?

At least two patents filed or granted this month.

USA- Methods and systems for detecting obstacles for a visual prosthesis

EU - ELECTRODE WITH INCREASED STABILITY AND METHOD OF MANUFACTURING THE SAME

Don't agree with the reasoning but also find it odd that I cannot access the EYES site on that website...

Dilution? I’m not sure that makes sense in this context.

I think there are other ways to interpret this news. We'll see.

EYES patent granted yesterday in EU.

Patent originally applied for in 2007. This suggests to me that their technology is still state of the art.

https://data.epo.org/publication-server/pdf-document?pn=2035079&ki=B1&cc=EP

Excellent points. After reading the Prospectus from a few months back and last quarterly filing, I believe M&A is more likely than them trying to go it alone.

What's next for EYES?